Replies to post #759 on Soligenix Inc (SNGX)

[jb_118]

OT: AVNR

I'm not sure what you're trying to say.

The FDA raised serious safety and possibly efficacy concerns about AVNR's drug, demanded new trials with different formulations, saying that all the trials that had been done were with a does of quinidine that was unapprobable. It's been a year, they've lost every major officer, have a sub $90M market cap, and haven't even started new trials yet.

They were destroyed.